Who invested in Plakous Therapeutics

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$10Kraised across 1 round since 2022, from 1 source

Latest round: Grant, $10KDec 2022
Investors: 2

See who backed them

The rounds

Dec 2022
Grant$10K
- One North Carolina Small Business Program
- North Carolina Biotechnology Center
Source recorded

Founders and team

From Plakous Therapeutics's own website and the SEC filings it signed: 1 founder, 4 on the team.

Scott A. WashburnFounder, President, and Chief Medical OfficerNamed on its 2020 Form D

Robert W. BoyceChief Executive Officer
Michael BergerVice President of Engineering
Jenna HojnackiResearch Associate
Seth A. TomblynSecretary and Treasureri

On the board, as filediAllison London BrownPeter A. Johnson

Everyone who backed them

One North Carolina Small Business ProgramInvestment firm1round

North Carolina Biotechnology CenterGovernment1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Plakous Therapeutics

Who invested in Plakous Therapeutics?

Plakous Therapeutics's investors include One North Carolina Small Business Program and North Carolina Biotechnology Center.

How much has Plakous Therapeutics raised?

Plakous Therapeutics has raised $10K across 1 round since 2022.

When did Plakous Therapeutics last raise?

Plakous Therapeutics's most recent round was a Grant of $10K in Dec 2022.

What was Plakous Therapeutics's biggest round?

Its most recent round, $10K in Dec 2022, is also its largest on record.

Who backed Plakous Therapeutics first?

Plakous Therapeutics's first round on record, in Dec 2022, was backed by One North Carolina Small Business Program and North Carolina Biotechnology Center.